Commerzbank Aktiengesellschaft FI Reduces Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Commerzbank Aktiengesellschaft FI lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 6.7% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 46,624 shares of the healthcare conglomerate's stock after selling 3,363 shares during the period. Commerzbank Aktiengesellschaft FI's holdings in UnitedHealth Group were worth $24,419,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of UNH. Marshall & Sterling Wealth Advisors Inc. purchased a new position in UnitedHealth Group during the fourth quarter valued at approximately $26,000. Hurley Capital LLC purchased a new position in UnitedHealth Group in the 4th quarter worth approximately $28,000. Aster Capital Management DIFC Ltd purchased a new position in UnitedHealth Group in the 4th quarter worth approximately $30,000. Kapitalo Investimentos Ltda purchased a new position in UnitedHealth Group in the 4th quarter worth approximately $41,000. Finally, Copia Wealth Management purchased a new position in UnitedHealth Group in the 4th quarter worth approximately $42,000. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Stock Down 1.5%

NYSE:UNH traded down $4.46 during mid-day trading on Thursday, hitting $288.03. 14,738,720 shares of the company's stock were exchanged, compared to its average volume of 7,770,851. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85. The business has a fifty day moving average price of $308.39 and a 200 day moving average price of $436.45. The company has a market cap of $261.28 billion, a PE ratio of 12.06, a P/E/G ratio of 1.42 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The business had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same period in the previous year, the firm earned $6.91 EPS. Equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were paid a dividend of $2.21 per share. The ex-dividend date was Monday, June 16th. This represents a $8.84 annualized dividend and a yield of 3.07%. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's payout ratio is presently 37.02%.

Analyst Upgrades and Downgrades

UNH has been the subject of a number of research reports. Argus cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Monday, April 21st. Wolfe Research cut their price objective on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a research note on Tuesday, May 20th. Barclays reaffirmed an "overweight" rating on shares of UnitedHealth Group in a research note on Thursday. Baird R W cut shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, June 11th. Finally, KeyCorp lowered their price target on shares of UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating for the company in a report on Monday, June 2nd. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have issued a buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $414.35.

Insider Activity at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 589 shares of the stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the sale, the chief executive officer directly owned 10,398 shares of the company's stock, valued at approximately $3,171,390. This represents a 5.36% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO John F. Rex acquired 17,175 shares of the business's stock in a transaction that occurred on Friday, May 16th. The shares were purchased at an average cost of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the transaction, the chief financial officer directly owned 203,796 shares in the company, valued at $59,329,091.52. The trade was a 9.20% increase in their position. The disclosure for this purchase can be found here. Insiders bought a total of 109,408 shares of company stock worth $31,607,768 in the last ninety days. 0.28% of the stock is currently owned by company insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.